IP Library Granted Patent US 11,352,323
Granted Patent B2
US 11,352,323 · App. 17/145,109 · Granted Jun 7, 2022

Processes for making, and methods of using, glycopyrronium compounds

Inventor: Anthony Adrian Shaw (Redwood City, CA)
Assignee: Journey Medical Corporation
C07D207/12C07B57/00A61P43/00C07B2200/07
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,352,323
App. No.
17/145,109
Granted
Jun 7, 2022
Kind
B2
Abstract

Provided herein are processes for making and methods of using salts of glycopyrronium, including solid forms and forms suitable for use as topicals. Disclosed here are processes for making salts of glycopyrronium, also processes for making compositions comprising salts of glycopyrronium, and methods of treating hyperhidrosis with salts of glycopyrronium as well as with compositions comprising salts of glycopyrronium such as, but not limited to, topical compositions. Disclosed herein are methods of treating hyperhidrosis including administering salts of glycopyrronium to subjects in need thereof.

Claims (18)

1. A process of making a compound of Formula (Ib):

wherein R 1 is alkyl;

comprising:

step (3): providing a compound (5):

step (4): contacting compound (5) with an alkyl amine to form a compound of Formula Ibc:

and

contacting compound (Ibc) with a reducing agent to form a compound of Formula (Ib):

2. The process of claim 1 , wherein R 1 is alkyl.

3. The process of claim 2 , wherein R 1 is methyl, ethyl, n-propyl, i-propyl, n-butyl, t-butyl, i-butyl, n-pentyl, or i-pentyl.

4. The process of claim 3 , wherein R 1 is methyl or ethyl.

5. The process of claim 3 , wherein R 1 is methyl.

6. The process of claim 3 , wherein R 1 is ethyl.

7. The process of claim 1 , wherein the compound of Formula (Ib) is compound (7):

8. The process of claim 1 , wherein compound (6) is made by contacting R(−)-malic acid, compound (5), with methyl amine:

9. The process of claim 1 , wherein R(−)-malic acid, compound (5), is made by isolating R(−)-malic acid, compound (5), from a mixture of R(−)-malic acid and L(+)-malic acid.

10. The process of claim 1 , wherein R(−)-malic acid, compound (5), is made by isolating R(−)-malic acid, compound (5), from a racemic mixture comprising compound (5).

11. The process of claim 1 , wherein the reducing agent is selected from a vitride, DIBAL, BH 3 , LiAlH 4 , silanes, and LiBH 4 .

12. The process of claim 11 , wherein the vitride is Red-Al.

Assignments (2)
SECURITY INTEREST Recorded Dec 28, 2023
From: JOURNEY MEDICAL CORPORATION; JG PHARMA, INC.
To: SWK FUNDING LLC
Reel/Frame 066157/0079 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 12, 2021
From: DERMIRA, INC.
To: JOURNEY MEDICAL CORPORATION
Reel/Frame 056829/0767 →
Continuity (3)
Division 16320999
Provisional Application 62370172 · Aug 2, 2016
Related Publication 20210130289A1 · May 6, 2021